Researchers have developed a groundbreaking eye drop treatment that slows vision loss in animal models of retinitis ...

Swiss eyecare firm Alcon said on Monday it has agreed to a deal worth a potential $430 million with US counterpart Lensar, ...

Surrozen is discontinuing its sole clinical-stage candidate and pivoting to its preclinical ophthalmology pipeline after the ...

Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a ...

The NFL free agent negotiation period started at 12 a.m. ET on Monday, March 10. Teams are now allowed to negotiate contracts with external free agents. The offseason isn't only about the open ...

The S&P 500 was down 1.8% in late trading and resuming its slide after a mini-recovery from the prior day helped it claw back some of its sharp drop over recent weeks. The Dow Jones Industrial Average ...

Michael K. Jensen, B.S.Pharm., M.S., is Clinical Associate Professor of Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City, and Clinical ...

The three types of eye care professionals are optometrists, ophthalmologists, and opticians. An optometrist is licensed to examine eyes and diagnose and treat eye problems. An ophthalmologist performs ...

Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solution The approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Bromfenac ...